Navigation Links
IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer
Date:11/17/2009

HOUSTON, Nov. 17 /PRNewswire/ -- IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced it has named Christopher M. Owens its President and Chief Executive Officer, effective immediately.

"Chris has a proven track record of results-based leadership and is the right person to take the Company to the next level," said Board Chairman Rick Anderson. "Chris has a clear vision and strategy of how we will advance IDEV through an explosive growth phase. We are confident and proud to have Chris leading the organization."

Mr. Owens has nearly 20 years of medical device experience holding senior-level executive positions in both the commercial and technical areas. Prior to coming to IDEV, he was Vice President of Worldwide Marketing for MicroVention from 2005-2008, a start-up medical device company that was purchased by Terumo Corporation. From 2003-2005, he was Vice President, Global Research and Development for the Surgical Division of Bausch & Lomb. Mr. Owens earned a bachelor's degree and a master's degree in Plastics Engineering from the University of Massachusetts, Lowell, and an MBA from the University of Phoenix.

The Company also appointed veteran medical device executive William W. Burke to Executive Vice President and Chief Financial Officer. Mr. Burke has more than 25 years of medical technology experience as a board member, senior executive and acquisition and financing advisor. He currently serves on the board of directors of Medical Action Industries, Inc. and Aperio Technologies, Inc. From 2004 through 2007, he was Executive Vice President and Chief Financial Officer of ReAble Therapeutics, Inc. From 2001 to 2004, he served as Chief Financial Officer of Cholestech Corporation. Most recently, he served as President of Emergent Technologies, Inc. He earned a BBA in finance from the University of Texas at Austin and an MBA from The Wharton Graduate Business School at the University of Pennsylvania.

"Bill's extensive experience and capabilities as a CFO and healthcare executive will enable IDEV to accelerate our growth strategy," Mr. Anderson said. "We believe that Chris and Bill provide IDEV with an impressive combination of senior executive leadership, skills and experience. Under the leadership of these talented individuals, we look forward to a prosperous future."

"I believe we are building a strong foundation for growth and expansion for the treatment of biliary and peripheral artery disease," Mr. Owens said. "We have a robust technology portfolio and we will be expanding and leveraging our technologies into other markets, where it makes sense to do so."

In anticipation of future growth, IDEV has recently moved into an expanded, world-class facility in Webster, TX, Mr. Owens added.

About IDEV Technologies, Incorporated

IDEV Technologies, Incorporated (IDEV) is an innovator and developer of next generation medical devices for use in the interventional radiology, vascular surgery and cardiology device marketplace. IDEV worldwide headquarters is located in Webster, Texas with the European headquarters in Beuningen, Netherlands.

    Contact:  Julie Nguyen, Marketing Communications Manager
              IDEV Technologies, Incorporated
              (281) 525-2000

SOURCE IDEV Technologies, Incorporated


'/>"/>
SOURCE IDEV Technologies, Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
3. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
4. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
5. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
8. Senesco Technologies Initiates Preclinical Studies for Cancer Target
9. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
10. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
11. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2017)... 3, 2017  Opioid addiction and other drugs of ... costs and threatening outcomes, were problems taken on directly ... industry that support them, met this week. This according ... that drugs of abuse, procalcitonin and acute kidney injury ... organization,s 69th meeting in San Diego, CA. ...
(Date:8/2/2017)... WASHINGTON , Aug. 2, 2017 CaryRx, a ... same day delivery service for patients in the ... the traditional retail pharmacy by providing delivery of medications through ... scheduled for future delivery or delivered within one hour to ... "We are excited to bring this invaluable service to ...
(Date:7/31/2017)... 7D Surgical, developer of ground breaking surgical navigation technologies, announced ... to support its strategic sales plan in Maryland ... 7D Surgical has entered into an exclusive sales representative agreement ... within those markets. ... Spartan Medical Purchases 7D Surgical ...
Breaking Medicine Technology:
(Date:8/22/2017)... ... 22, 2017 , ... Pivot Point Consulting, a ... as the firm’s new Consulting Services Executive. Mr. Tisch will oversee all aspects ... assisting clients with initial vendor selection and pre-implementation planning through go-live support and ...
(Date:8/22/2017)... ... August 22, 2017 , ... “To Walk Away”: a ... B17 bomber named Edward Koontz. “To Walk Away” is the creation of published author, ... published over two hundred manuscripts in chemistry and religion, as well as four novels. ...
(Date:8/22/2017)... Raleigh, North Carolina (PRWEB) , ... August 22, ... ... senior strategic advisor. Mr. Stewart is the Founder and Managing Member for t4 ... elements that have become critical to his definition of “success”: physician leadership development, ...
(Date:8/21/2017)... ... 22, 2017 , ... Nanoparticle research provides an exciting path ... learning and implementing best practices for containment using ventilated safety enclosures, many of ... a better understanding of a method for safely testing nanotechnology hoods. They will ...
(Date:8/21/2017)... , ... August 21, 2017 , ... Five chefs from ... awareness for Alzheimer’s Family Center. , Guests will be able to vote for ... Plaza, Braised Lamb Shank with Fennel Dill Salad, Feta Cheese Sauce & Garlic Pita ...
Breaking Medicine News(10 mins):